Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Atropine products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An anticholinergic medication used to increase heart rate, reduce secretions, and dilate the pupil.
Products affected
1 / 10
In shortage since
Nov 1, 2020
Reports on file
31
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ATROPINE
1% · SOLUTION
SOLUTION · PHARMA STULLN INC.
DIN 02023695 · since Nov 1, 2020, no end estimate · Delay in shipping of the drug.
Resolved
ATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Aug 18, 2025 · Disruption of the manufacture of the drug.
Discontinued
ATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154
Resolved
ATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Aug 15, 2024 · Disruption of the manufacture of the drug.
Resolved
ATROPINE INJECTION BP
0.6MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02432196 · ended Apr 16, 2024 · Demand increase for the drug.
Resolved
ATROPINE INJECTION BP
0.4MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02432188 · ended Apr 15, 2024 · Demand increase for the drug.
Resolved
MINIMS ATROPINE SULPHATE
1% · DROPS · BAUSCH & LOMB INC
DIN 02148358 · ended Jan 30, 2024 · Shortage of an inactive ingredient or component.
Resolved
ALCON ATROPINE
1% · SOLUTION · ALCON CANADA INC
DIN 00035017 · ended Sep 24, 2023 · Requirements related to complying with good manufacturing practices.
Resolved
ATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Feb 3, 2023 · Disruption of the manufacture of the drug.
Resolved
ATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Aug 10, 2022 · Demand increase for the drug.
Resolved
ATROPINE SULFATE INJECTION USP
.6MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 00392693 · ended Jul 13, 2022 · Demand increase for the drug.
Resolved
ATROPINE SULFATE INJECTION
1MG · SOLUTION · LABORATOIRE AGUETTANT
DIN 02426277 · ended Jun 8, 2022 · Demand increase for the drug.
Showing 12 of 31 reports. All reports are on file with Health Canada.
What's happening
Atropine is currently affected by an active shortage report filed with Health Canada by PHARMA STULLN INC..
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Atropine is classified under “BELLADONNAAND DERIVATIVES, PLAIN” (ATC A03BA).
Recent changes
No changes recorded yet.
Common questions
What is Atropine used for?
An anticholinergic medication used to increase heart rate, reduce secretions, and dilate the pupil.
When will Atropine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Atropine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.